Newstral
Article
The Globe and Mail on 2017-10-02 22:28
Growers of human heart cells, Canadian-backed biotech firm Novoheart prepares for IPO
Related news
- The latest biotech breakthrough: tiny, beating 'hearts' made from stem cellsCBC
- Vancouver biotech firm Absci files for IPOoregonlive.com
- Canada Goose prepares for IPO: sourcesThe Globe and Mail
- Canada biotech renaissance continues with IPO filing by Montreal’s ClementiaThe Globe and Mail
- BAmazon-Backed Deliveroo Chooses London for $7 Billion IPObarrons.com
- CBitfury-Backed Bitcoin Miner Hub 8 Prepares to Go Publiccoindesk.com
- Venture-backed Md. biotech files for IPObizjournals.com
- Bellevue's Apptio prepares for IPOThe Columbian
- Move over Juno: This company just had the largest biotech IPO everbizjournals.com
- High Point biotech firm launches IPObizjournals.com
- Seattle biotech Silverback Therapeutics prices upsized IPOseattletimes.com
- MKrystal Biotech boosts IPO share offeringmarketwatch.com
- MMoleculin Biotech raises $9.2 million in IPOmarketwatch.com
- Gaithersburg biotech firm files for IPObizjournals.com
- High Drama: Cannabis Biotech Firm Phylos Roils Small GrowersWired.com
- Onex-backed Emerald seeks to raise $310-million in New York IPOThe Globe and Mail
- Gates-Backed IPO Could Revolutionize Drug DevelopmentForbes
- Meituan, the Tencent-backed “one-stop super app,” files for IPO in Hong KongTechCrunch
- Peter Thiel-backed psychedelic drug maker aims to raise $100M in IPONew York Post
- SBeijing short video ad agency backed by ByteDance and Xiaomi files for IPO in Hong Kongscmp.com